119 related articles for article (PubMed ID: 28510277)
21. Acquired resistance to chlorhexidine - is it time to establish an 'antiseptic stewardship' initiative?
Kampf G
J Hosp Infect; 2016 Nov; 94(3):213-227. PubMed ID: 27671220
[TBL] [Abstract][Full Text] [Related]
22. Comparison of four antiseptic products containing chlorhexidine gluconate.
Larson EL; Laughon BE
Antimicrob Agents Chemother; 1987 Oct; 31(10):1572-4. PubMed ID: 3435105
[TBL] [Abstract][Full Text] [Related]
23. An interesting increase in immediate and residual efficacy of a trade mark of alcoholic 2% chlorhexidine gluconate, with and without dye, has been demonstrated by an in vitro study with ATCC micro-organisms and strains isolated from ICU patients.
Herruzo R; Vizcaino MJ; de la Cruz JJ; Crosby C; Casey A
J Appl Microbiol; 2020 May; 128(5):1339-1346. PubMed ID: 31860146
[TBL] [Abstract][Full Text] [Related]
24. Quinocetone triggers oxidative stress and induces cytotoxicity and genotoxicity in human peripheral lymphocytes of both genders.
Yang W; Fu J; Xiao X; Yan H; Bao W; Wang D; Hao L; Nussler AK; Yao P; Liu L
J Sci Food Agric; 2013 Apr; 93(6):1317-25. PubMed ID: 23027643
[TBL] [Abstract][Full Text] [Related]
25. Chlorhexidine gluconate--the solution for dental problems.
Robinson JG
J Vet Dent; 1995 Mar; 12(1):29-31. PubMed ID: 9693624
[TBL] [Abstract][Full Text] [Related]
26. Melatonin as a candidate therapeutic drug for protecting bone cells from chlorhexidine-induced damage.
Proksch S; Strobel SL; Vach K; Abouassi T; Tomakidi P; Ratka-Krüger P; Hellwig E
J Periodontol; 2014 Dec; 85(12):e379-89. PubMed ID: 25153702
[TBL] [Abstract][Full Text] [Related]
27. Preadmission Application of 2% Chlorhexidine Gluconate (CHG): Enhancing Patient Compliance While Maximizing Skin Surface Concentrations.
Edmiston CE; Krepel CJ; Spencer MP; Ferraz AA; Seabrook GR; Lee CJ; Lewis BD; Brown KR; Rossi PJ; Malinowski MJ; Edmiston SE; Ferraz EM; Leaper DJ
Infect Control Hosp Epidemiol; 2016 Mar; 37(3):254-9. PubMed ID: 26708510
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of chlorhexidine gluconate on skin by incompatible alcohol hand sanitizing gels.
Kaiser N; Klein D; Karanja P; Greten Z; Newman J
Am J Infect Control; 2009 Sep; 37(7):569-73. PubMed ID: 19398245
[TBL] [Abstract][Full Text] [Related]
29. The impact of chlorhexidine gluconate on the skin microbiota of children and adults: A pilot study.
Kates AE; Zimbric ML; Mitchell K; Skarlupka J; Safdar N
Am J Infect Control; 2019 Aug; 47(8):1014-1016. PubMed ID: 30879799
[TBL] [Abstract][Full Text] [Related]
30. Desquamating vaginal mucosa from chlorhexidine gluconate.
Shippey SH; Malan TK
Obstet Gynecol; 2004 May; 103(5 Pt 2):1048-50. PubMed ID: 15121604
[TBL] [Abstract][Full Text] [Related]
31. Effect of chlorhexidine digluconate on different cell types: a molecular and ultrastructural investigation.
Giannelli M; Chellini F; Margheri M; Tonelli P; Tani A
Toxicol In Vitro; 2008 Mar; 22(2):308-17. PubMed ID: 17981006
[TBL] [Abstract][Full Text] [Related]
32. Measuring residual activity of topical antimicrobials: is the residual activity of chlorhexidine an artefact of laboratory methods?
Rutter JD; Angiulo K; Macinga DR
J Hosp Infect; 2014 Oct; 88(2):113-5. PubMed ID: 25078726
[TBL] [Abstract][Full Text] [Related]
33. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin.
Bashir MH; Olson LK; Walters SA
Am J Infect Control; 2012 May; 40(4):344-8. PubMed ID: 21737178
[TBL] [Abstract][Full Text] [Related]
34. Cell surface hydrophobicity of oral Candida dubliniensis isolates following limited exposure to sub-therapeutic concentrations of chlorhexidine gluconate.
Ellepola AN; Joseph BK; Khan ZU
Mycoses; 2013 Jan; 56(1):82-8. PubMed ID: 22533484
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections.
Suwantarat N; Carroll KC; Tekle T; Ross T; Maragakis LL; Cosgrove SE; Milstone AM
Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1183-6. PubMed ID: 25111928
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial Activity of a Novel Vascular Access Film Dressing Containing Chlorhexidine Gluconate.
Wibaux A; Thota P; Mastej J; Prince DL; Carty N; Johnson P
PLoS One; 2015; 10(11):e0143035. PubMed ID: 26599087
[TBL] [Abstract][Full Text] [Related]
37. Residual antimicrobial effect of chlorhexidine digluconate and octenidine dihydrochloride on reconstructed human epidermis.
Müller G; Langer J; Siebert J; Kramer A
Skin Pharmacol Physiol; 2014; 27(1):1-8. PubMed ID: 23887383
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel.
Lampe MF; Ballweber LM; Stamm WE
Antimicrob Agents Chemother; 1998 Jul; 42(7):1726-30. PubMed ID: 9661012
[TBL] [Abstract][Full Text] [Related]
39. The effect of brief exposure to sub-therapeutic concentrations of chlorhexidine gluconate on germ tube formation of oral Candida dubliniensis.
Ellepola AN
Mycoses; 2011 Sep; 54(5):e330-5. PubMed ID: 20557460
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a Standardized Preadmission Showering Regimen to Achieve Maximal Antiseptic Skin Surface Concentrations of Chlorhexidine Gluconate, 4%, in Surgical Patients.
Edmiston CE; Lee CJ; Krepel CJ; Spencer M; Leaper D; Brown KR; Lewis BD; Rossi PJ; Malinowski MJ; Seabrook GR
JAMA Surg; 2015 Nov; 150(11):1027-33. PubMed ID: 26308490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
